Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
USA | Ann: USA NTA 03-10-2024 $4.23940 | 07:32 | 0 | 18 | |||
|
|||||||
USA | Ann: USA NTA 02-10-2024 $4.20333 | 03/10/24 | 0 | 27 | |||
|
|||||||
USA | Ann: USA NTA 01-10-2024 $4.18903 | 02/10/24 | 0 | 33 | |||
|
|||||||
USA | Ann: USA NTA 30-09-2024 $4.19806 | 01/10/24 | 0 | 31 | |||
|
|||||||
USA | Ann: USA NTA 27-09-2024 $4.22354 | 30/09/24 | 0 | 42 | |||
|
|||||||
USA | Ann: USA NTA 26-09-2024 $4.22976 | 27/09/24 | 0 | 36 | |||
|
|||||||
USA | Ann: USA NTA 25-09-2024 $4.20785 | 26/09/24 | 0 | 42 | |||
|
|||||||
USA | Ann: USA NTA 24-09-2024 $4.24472 | 25/09/24 | 0 | 53 | |||
|
See All Discussions